Research ArticleCancer

Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy

See allHide authors and affiliations

Science Translational Medicine  21 May 2014:
Vol. 6, Issue 237, pp. 237ra67
DOI: 10.1126/scitranslmed.3007974

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article